# A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

> **NCT04873700** · — · COMPLETED · sponsor: **Takeda** · enrollment: 335 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Colitis, Ulcerative
- Crohn Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04873700
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-30
- **Primary completion:** 2022-05-17
- **Final completion:** 2022-05-17
- **Target enrollment:** 335 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873700, "A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04873700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*